Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5337685> ?p ?o }
Showing triples 1 to 41 of
41
with 100 triples per page.
- Q5337685 subject Q6762709.
- Q5337685 subject Q7050887.
- Q5337685 subject Q8760145.
- Q5337685 abstract "Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, Edge's lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, Edge's second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain.EG-1962 and EG-1964 both utilize Edge’s proprietary, programmable, biodegradable polymer-based development platform, known as Precisa™. The Precisa platform allows Edge to create therapeutics capable of delivering medicines directly to the site of injury, providing a novel delivery mechanism that enables targeted and sustained drug exposure while potentially avoiding the systemic, dose-limiting side effects often associated with current standards of care.".
- Q5337685 foundingYear "2009".
- Q5337685 industry Q7108.
- Q5337685 keyPerson Q484876.
- Q5337685 location Q820857.
- Q5337685 wikiPageExternalLink 0815449D:US-edge-therapeutics-inc.
- Q5337685 wikiPageExternalLink www.edgetherapeutics.com.
- Q5337685 wikiPageWikiLink Q1198391.
- Q5337685 wikiPageWikiLink Q1995526.
- Q5337685 wikiPageWikiLink Q3144926.
- Q5337685 wikiPageWikiLink Q421429.
- Q5337685 wikiPageWikiLink Q484876.
- Q5337685 wikiPageWikiLink Q669597.
- Q5337685 wikiPageWikiLink Q6762709.
- Q5337685 wikiPageWikiLink Q693442.
- Q5337685 wikiPageWikiLink Q7050887.
- Q5337685 wikiPageWikiLink Q7108.
- Q5337685 wikiPageWikiLink Q7916887.
- Q5337685 wikiPageWikiLink Q820857.
- Q5337685 wikiPageWikiLink Q8760145.
- Q5337685 foundation "2009".
- Q5337685 homepage www.edgetherapeutics.com.
- Q5337685 industry Q7108.
- Q5337685 keyPeople "Brian Leuthner R Loch Macdonald".
- Q5337685 location "Berkeley Heights, NJ, U.S.".
- Q5337685 name "Edge Therapeutics".
- Q5337685 type Organization.
- Q5337685 type Agent.
- Q5337685 type Company.
- Q5337685 type Organisation.
- Q5337685 type Agent.
- Q5337685 type SocialPerson.
- Q5337685 type Thing.
- Q5337685 type Q43229.
- Q5337685 comment "Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions.".
- Q5337685 label "Edge Therapeutics".
- Q5337685 homepage www.edgetherapeutics.com.
- Q5337685 name "Edge Therapeutics".